[DOI] [PMC free article] [PubMed] [Google Scholar] 66.Nielsen CK, hrstrm CC, Houji IJK, et al
For UK patients, it is worth noting that any discussion of 'Adderall' typically translates to consideration of licensed UK alternatives such as lisdexamfetamine (Elvanse) or methylphenidate preparations, as these are the stimulant medications actually available through NHS and private prescriptions in Britain
Furthermore, because both berberine and ALA independently and aggressively lower blood glucose levels, combining them with prescription anti-diabetic medications (such as metformin, sulfonylureas, or exogenous insulin) drastically increases the risk of severe hypoglycemia
In addition to reviewing the updated List and Summary of Major Changes from WADA, athletes and support personnel including parents, coaches, and medical professionals should take time to review some highlights and additional explanations from the relatively minor changes for 2019: CLARIFICATION ON ANABOLIC AGENTS The title of S1.1b Endogenous Anabolic Androgenic Steroids (AAS) when administered exogenously was changed to Endogenous AAS and their Metabolites and isomers when administered exogenously. This change was made to clarify that all endogenous AAS and their metabolites and isomers are prohibited when administered exogenously
